These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 17634518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
    Sherwood A, Bower JK, McFetridge-Durdle J, Blumenthal JA, Newby LK, Hinderliter AL.
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023
    [Abstract] [Full Text] [Related]

  • 3. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM.
    Menopause; 2008 Aug; 15(6):1060-4. PubMed ID: 18521047
    [Abstract] [Full Text] [Related]

  • 4. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment.
    Gungor F, Kalelioglu I, Turfanda A.
    Angiology; 2009 Aug; 60(3):308-17. PubMed ID: 18505742
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
    Phillips TJ, Symons J, Menon S, HT Study Group.
    J Am Acad Dermatol; 2008 Sep; 59(3):397-404.e3. PubMed ID: 18625536
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy and coronary artery disease: buried alive?
    Bahl VK, Naik N.
    Indian Heart J; 2002 Sep; 54(1):23-30. PubMed ID: 11999084
    [No Abstract] [Full Text] [Related]

  • 8. The applicability of hormonal effects on atherosclerosis in animals to heart disease in postmenopausal women.
    Wagner JD, Clarkson TB.
    Semin Reprod Med; 2005 May; 23(2):149-56. PubMed ID: 15852200
    [Abstract] [Full Text] [Related]

  • 9. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [Abstract] [Full Text] [Related]

  • 10. Postmenopausal Hormone Therapy and Atherosclerosis--Time Is of the Essence.
    Keaney JF, Solomon CG.
    N Engl J Med; 2016 Mar 31; 374(13):1279-80. PubMed ID: 27028919
    [No Abstract] [Full Text] [Related]

  • 11. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B, Icin T, Kovacev N.
    Med Pregl; 2009 Mar 31; 62 Suppl 3():85-90. PubMed ID: 19702123
    [Abstract] [Full Text] [Related]

  • 12. Hormone replacement therapy in postmenopausal women: emerging hope for future.
    Gambhir DS, Gambhir JK.
    Indian Heart J; 1998 Mar 31; 50(1):19-21. PubMed ID: 9583282
    [No Abstract] [Full Text] [Related]

  • 13. [Novofem--innovation in hormone replacement therapy].
    Dukovski A, Gerganova A.
    Akush Ginekol (Sofiia); 2003 Mar 31; 42 Suppl 2():38-9. PubMed ID: 14619755
    [No Abstract] [Full Text] [Related]

  • 14. [Activelle - modern low-dose hormone replacement therapy for postmenopausal women].
    Novo Nordisk..
    Akush Ginekol (Sofiia); 2000 Mar 31; 39 Suppl 2():28-30. PubMed ID: 11188014
    [No Abstract] [Full Text] [Related]

  • 15. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same. Do all the patients have the same characteristics?].
    Mathelin C, Brettes JP.
    Gynecol Obstet Fertil; 2007 Jun 31; 35(6):502-3. PubMed ID: 17543563
    [No Abstract] [Full Text] [Related]

  • 16. Con: Postmenopausal hormone replacement therapy does not improve outcome in women undergoing coronary artery bypass graft surgery.
    Tamis-Holland JE, James JH.
    J Cardiothorac Vasc Anesth; 2001 Aug 31; 15(4):523-5. PubMed ID: 11505360
    [No Abstract] [Full Text] [Related]

  • 17. Cardiovascular risk associated with hormone replacement therapy: some critical questions about the type of estrogen used in most clinical trials.
    Subbiah MT.
    Atherosclerosis; 2004 Apr 31; 173(2):373-4. PubMed ID: 15064116
    [No Abstract] [Full Text] [Related]

  • 18. [Postmenopausal estrogens also for the heart! Postmenopausal hormone replacement--mechanisms of action].
    Wildenrath C.
    Fortschr Med; 1995 Sep 10; 113(25):48-9. PubMed ID: 7498852
    [No Abstract] [Full Text] [Related]

  • 19. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Sep 10; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]

  • 20. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E, Canfell K.
    Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.